SREBF1 and lipodystrophy: To understand the pathophysiology of lipodystrophy and evaluate the efficacy and safety of clinical treatments, several transgenic mouse models that mimic the features of lipodystrophy, such as aP2-SREBP-1c mouse [11-13] and A-ZIP/F1 mouse [14-16], have been established.